Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 38 Records) |
| Query Trace: Melanoma and MET[original query] |
|---|
| Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma. Familial cancer 2014 Dec 13 (4): 645-9. de Ávila Alexandre Leon Ribeiro, Krepischi Ana Cristina Victorino, Moredo Luciana Facure, Aguiar Talita Ferreira Marques, da Silva Felipe Carneiro, de Sá Bianca Costa Soares, de Nóbrega Amanda França, Achatz Maria Isabel Waddington, Duprat João Pedreira, Landman Gilles, Carraro Dirce Mar |
| BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genetics in medicine : official journal of the American College of Medical Genetics 2015 Jul 17 (7): 569-77. Zhen David B, Rabe Kari G, Gallinger Steven, Syngal Sapna, Schwartz Ann G, Goggins Michael G, Hruban Ralph H, Cote Michele L, McWilliams Robert R, Roberts Nicholas J, Cannon-Albright Lisa A, Li Donghui, Moyes Kelsey, Wenstrup Richard J, Hartman Anne-Renee, Seminara Daniela, Klein Alison P, Petersen Gloria |
| Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway. Nature genetics 2015 Sep . Shain A Hunter, Garrido Maria, Botton Thomas, Talevich Eric, Yeh Iwei, Sanborn J Zachary, Chung Jongsuk, Wang Nicholas J, Kakavand Hojabr, Mann Graham J, Thompson John F, Wiesner Thomas, Roy Ritu, Olshen Adam B, Gagnon Alexander, Gray Joe W, Huh Nam, Hur Joe S, Busam Klaus J, Scolyer Richard A, Cho Raymond J, Murali Rajmohan, Bastian Boris |
| Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls. PloS one 2015 10 (6): e0128829. Cao Jin-Lin, Yuan Ping, Abuduwufuer Abudumailamu, Lv Wang, Yang Yun-Hai, Hu Ji |
| High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients. Melanoma research 2015 Mar . van den Hurk Karin, Balint Balazs, Toomey Sinead, O'Leary Patrick C, Unwin Louise, Sheahan Kieran, McDermott Enda W, Murphy Ian, van den Oord Joost J, Rafferty Mairin, FitzGerald Dara M, Moran Julie, Cummins Robert, MacEneaney Owen, Kay Elaine W, O'Brien Cathal P, Finn Stephen P, Heffron Cynthia C B B, Murphy Michelle, Yela Ruben, Power Derek G, Regan Padraic J, McDermott Clodagh M, O'Keeffe Allan, Orosz Zsolt, Donnellan Paul P, Crown John P, Hennessy Bryan T, Gallagher William |
| Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature? Cancer biology & therapy 2015 Dec 0. Di Lorenzo Sara, Fanale Daniele, Corradino Bartolo, Calo Valentina, Rinaldi Gaetana, Bazan Viviana, Giordano Antonio, Cordova Adriana, Russo Anton |
| A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variants. International journal of cancer 2016 Jun . Vaysse Amaury, Fang Shenying, Brossard Myriam, Wei Qingyi, Chen Wei V, Mohamdi Hamida, Vincent-Fetita Lynda, Margaritte-Jeannin Patricia, Lavielle Nolwenn, Maubec Eve, Lathrop Mark, Avril Marie-Françoise, Amos Christopher I, Lee Jeffrey E, Demenais Floren |
| Neurofibromin protein loss in desmoplastic melanoma subtypes: implicating NF1 allelic loss as a distinct genetic driver? Human pathology 2016 Mar . Kadokura Alexander, Frydenlund Noah, Leone Dominick A, Yang Shi, Hoang Mai P, Deng April, Hernandez-Perez Marier, Biswas Asok, Singh Rajendra, Yaar Ron, Mahalingam Mee |
| Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients. Journal of cancer research and clinical oncology 2016 Dec . Ofner Richard, Ritter Cathrin, Heidenreich Barbara, Kumar Rajiv, Ugurel Selma, Schrama David, Becker Jürgen |
| Metastatic melanoma patients' sensitivity to ipilimumab cannot be predicted by tumor characteristics. International journal of surgery. Oncology 2017 11 2 (9): e43. Rossfeld Kara, Hade Erinn M, Gangi Alexandra, Perez Matthew, Kinsey Emily N, Grabska Joanna, Ederle Ashley, Zager Jonathan, Salama April K, Olencki Thomas E, Beasley Georgia |
| Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review. Frontiers in oncology 2017 10 7 233. Jessurun Charissa A C, Vos Julien A M, Limpens Jacqueline, Luiten Rosalie |
| Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples. Human pathology 2018 8 82 206-214. Yang Shi, Leone Dominick A, Biswas Asok, Deng April, Jukic Drazen, Singh Rajendra, Sundram Uma, Mahalingam Mee |
| An insight into the molecular genetics of a uveal melanoma patient cohort. Journal of cancer research and clinical oncology 2018 7 144 (10): 1861-1868. Kennedy Susan, Rice Michael, Toomey Sinead, Horgan Noel, Hennessey Bryan T, Larkin Annemar |
| Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study. BMC cancer 2019 Aug 19 (1): 772. Casula Milena, Paliogiannis Panagiotis, Ayala Fabrizio, De Giorgi Vincenzo, Stanganelli Ignazio, Mandalà Mario, Colombino Maria, Manca Antonella, Sini Maria Cristina, Caracò Corrado, Ascierto Paolo Antonio, Satta Rosanna Rita, , Lissia Amelia, Cossu Antonio, Palmieri Giuseppe, |
| Genomic analysis reveals low tumor mutation burden which may be associated with GNAQ/11 alteration in a series of primary leptomeningeal melanomas. Pigment cell & melanoma research 2019 10 33 (3): 458-465. Fortin Ensign Shannon, Bollin Kathryn, Millis Sherri Z, Hinds Brian R, Kosty Michael, Uchiyama Christoph |
| Dabrafenib and Trametinib in Patients With Tumors With BRAF Mutations: Results of the NCI-MATCH Trial Subprotocol H. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 8 38 (33): 3895-3904. Salama April K S, Li Shuli, Macrae Erin R, Park Jong-In, Mitchell Edith P, Zwiebel James A, Chen Helen X, Gray Robert J, McShane Lisa M, Rubinstein Larry V, Patton David, Williams P Mickey, Hamilton Stanley R, Armstrong Deborah K, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
| Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine. Cancers 2021 8 13 (15): . Gardrat Sophie, Houy Alexandre, Brooks Kelly, Cassoux Nathalie, Barnhill Raymond, Dayot Stéphane, Bièche Ivan, Raynal Virginie, Baulande Sylvain, Marais Richard, Roman-Roman Sergio, Stern Marc-Henri, Rodrigues Manu |
| NGS Analysis of Liquid Biopsy (LB) and Formalin-Fixed Paraffin-Embedded (FFPE) Melanoma Samples Using Oncomine™ Pan-Cancer Cell-Free Assay. Genes 2021 Jul 12 (7): . Olbryt Magdalena, Rajczykowski Marcin, Bal Wies?aw, Fiszer-Kierzkowska Anna, Cortez Alexander Jorge, Mazur Magdalena, Suwi?ski Rafa?, Wid?ak Wies?a |
| Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients. Journal of dermatological science 2021 Apr . Kaneko Akira, Kanemaru Hisashi, Kajihara Ikko, Mijiddorj Tselmeg, Miyauchi Hitomi, Kuriyama Haruka, Kimura Toshihiro, Sawamura Soichiro, Makino Katsunari, Miyashita Azusa, Aoi Jun, Makino Takamitsu, Masuguchi Shinichi, Fukushima Satoshi, Ihn Hirono |
| Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma. Cancers 2021 11 13 (22): . Terai Mizue, Shimada Ayako, Chervoneva Inna, Hulse Liam, Danielson Meggie, Swensen Jeff, Orloff Marlana, Wedegaertner Philip B, Benovic Jeffrey L, Aplin Andrew E, Sato Taka |
| Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA network open 2021 11 4 (11): e2132615. Gupta Sounak, Erickson Lori A, Lohse Christine M, Shen Wei, Pitel Beth A, Knight Shannon M, Halling Kevin C, Herrera-Hernandez Loren, Boorjian Stephen A, Thompson R Houston, Leibovich Bradley C, Jimenez Rafael E, Cheville John |
| Evaluation of MET Non-Exon-14 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e101. Li X, Wang |
| Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study. European journal of cancer (Oxford, England : 1990) 2022 5 169 146-155. Leyvraz Serge, Konietschke Frank, Peuker Caroline, Schütte Moritz, Kessler Thomas, Ochsenreither Sebastian, Ditzhaus Marc, Sprünken Erin D, Dörpholz Gina, Lamping Mario, Rieke Damian T, Klinghammer Konrad, Burock Susen, Ulrich Claas, Poch Gabriela, Schäfer Reinhold, Klauschen Frederick, Joussen Antonia, Yaspo Marie-Laure, Keilholz Ulri |
| Genomic comparison of malignant melanoma and atypical Spitz tumor in the pediatric population. Pediatric dermatology 2022 Feb . Church Alanna J, Moustafa Danna, Pinches Robert Seth, Hawryluk Elena B, Schmidt Birgitta A |
| Spitz Tumor With SQSTM1::NTRK2 Fusion: A Clinicopathological Study of 5 Cases. The American Journal of dermatopathology 2023 3 . Mansour Boulos, Vanecek Tomas, Kastnerova Liubov, Nosek Daniel, Kazakov Dmitry V, Donati Miche |
| Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
| The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
| Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1-Associated Genes in Finnish Patients with Uveal Melanoma. Pigment cell & melanoma research 2024 9 . Pauliina E Repo, Eveliina Jakkula, Juho Hiltunen, Heidi Putkuri, Aleksandra Staskiewicz-Tuikkanen, Reetta-Stiina Järvinen, Martin Täll, Virpi Raivio, Rana'a T Al-Jamal, Tero T Kivelä, Joni A Turun |
| MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study. BMC cancer 2024 11 24 (1): 1384. Xiaojun Cai, Jing Lin, Caili Li, Ting Xu, Chuanben Chen, Bin Lan, Xuefeng Wang, Shengjie Bai, Yufang Huang, Huishan Zhang, Lu Si, Yu Ch |
- Page last reviewed:Feb 1, 2024
- Content source: